News
-
-
-
PRESS RELEASE
Innodata Reports Second Quarter 2024 Results; Record 66% Revenue Growth Year-Over-Year
INNODATA INC. (Nasdaq: INOD) reports Q2 2024 results: Revenue up 66% YoY to $32.6M, EPS $0.00, Adjusted EBITDA $2.8M. Raised guidance to 60% revenue growth in 2024. Partnerships with Big Tech customers expand -
PRESS RELEASE
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Nanobiotix publie mensuellement le nombre total d'actions et de droits de vote, conformément aux règles de l'AMF. L'entreprise de biotechnologie révolutionne les traitements médicaux -
-
-
PRESS RELEASE
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. announces third quarter financial results for June 30, 2024, including operational highlights and future plans. Conference call/webcast today at 4:30 PM ET. View Form 10-Q at https://investors.adnas.com/sec-filings/ -
PRESS RELEASE
Amdocs Signs Multi-Year Managed Services Agreement with TELUS to Transform Monetization Operations
Amdocs partners with TELUS to migrate monetization operations to Amazon Web Services, enhancing flexibility and reducing costs. The move aims to improve customer experience and speed up product launches -
-